Cargando…

Iatrogenicity : Causes and Consequences of Iatrogenesis in Cardiovascular Medicine /

"Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This i...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Gussak, Ihor (Editor ), Kostis, John B. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New Brunswick, New Jersey : Rutgers University Press Medicine, 2018.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 JSTOR_on1029759751
003 OCoLC
005 20231005004200.0
006 m o d
007 cr cnu|||unuuu
008 180329s2018 nju ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d YDX  |d JSTOR  |d EBLCP  |d P@U  |d OCLCF  |d OCLCQ  |d K6U  |d UX1  |d OCLCQ  |d OCLCO  |d LUU  |d OCLCQ 
019 |a 1175641067 
020 |a 9780813586434  |q (electronic bk.) 
020 |a 0813586437  |q (electronic bk.) 
020 |a 0813586410 
020 |a 9780813586410 
020 |z 9780813586410 
035 |a (OCoLC)1029759751  |z (OCoLC)1175641067 
037 |a 22573/ctt1q0fh1t  |b JSTOR 
050 4 |a RC671 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
072 7 |a MED078000  |2 bisacsh 
072 7 |a MED112000  |2 bisacsh 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MED014000  |2 bisacsh 
072 7 |a MED010000  |2 bisacsh 
082 0 4 |a 616.106  |2 23 
049 |a UAMI 
245 0 0 |a Iatrogenicity :  |b Causes and Consequences of Iatrogenesis in Cardiovascular Medicine /  |c edited by Ihor B. Gussak and John B. Kostis ; co-edited by Ibrahim Akin [and five others]. 
264 1 |a New Brunswick, New Jersey :  |b Rutgers University Press Medicine,  |c 2018. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Online resource; title from PDF title page (EBSCO, viewed March 29, 2018). 
504 |a Includes bibliographical references and index. 
520 |a "Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. ."--  |c Provided by publisher 
505 0 |a Intro; Title Page; Copyright; Contents; Contributors; The Concept of Iatrogenicity; Part I: Medical Harm; Chapter 1. Iatrogenicity: Definition, History, and Modern Context; Chapter 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions; Chapter 3. Risk Management: The Medical Center Administration Perspective; Chapter 4. Iatrogenicity from the Patient's Perspective; Chapter 5. A Naturopathic Perspective on Iatrogenesis; Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs 
505 8 |a Chapter 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and SyndromesChapter 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Chapter 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension; Chapter 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes; Chapter 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics 
505 8 |a Chapter 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on PreeclampsiaChapter 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect; Chapter 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents; Chapter 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System; Chapter 16. Iatrogenicity and Antianginal Drugs; Chapter 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?; Chapter 18. Cardiovascular Iatrogenicity in Older Adults 
505 8 |a Part III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and SurgeriesChapter 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology; Chapter 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology; Chapter 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries; Chapter 22. Iatrogenic Aspects of Cardiac Electrophysiology; Chapter 23. Iatrogenic Aspects in Cardiac Device Therapy 
505 8 |a Chapter 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic ModalitiesPart IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications; Chapter 25. Trained Athletes; Chapter 26. Sports Cardiology; Chapter 27. Dangers of Lifestyle Modification Advice; Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine; Chapter 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications; Chapter 29. Interactions Between Supplements and Medications; Index 
590 |a JSTOR  |b Books at JSTOR All Purchased 
590 |a JSTOR  |b Books at JSTOR Evidence Based Acquisitions 
590 |a JSTOR  |b Books at JSTOR Demand Driven Acquisitions (DDA) 
650 0 |a Cardiovascular system  |x Diseases  |x Treatment. 
650 0 |a Iatrogenic diseases. 
650 2 |a Iatrogenic Disease 
650 6 |a Appareil cardiovasculaire  |x Maladies  |x Traitement. 
650 6 |a Maladies iatrogéniques. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Public Health.  |2 bisacsh 
650 7 |a Cardiovascular system  |x Diseases  |x Treatment.  |2 fast  |0 (OCoLC)fst00847218 
650 7 |a Iatrogenic diseases.  |2 fast  |0 (OCoLC)fst00966438 
700 1 |a Gussak, Ihor,  |e editor. 
700 1 |a Kostis, John B.,  |e editor. 
776 0 8 |i Print version:  |z 9780813586410 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.2307/j.ctt1q1cr8b  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL4789855 
938 |a EBSCOhost  |b EBSC  |n 1455653 
938 |a Project MUSE  |b MUSE  |n muse57922 
938 |a YBP Library Services  |b YANK  |n 15245802 
938 |a YBP Library Services  |b YANK  |n 15247127 
994 |a 92  |b IZTAP